PubMed · 1991 · 510 citations · 0 references
Life SciencesMolecular BiologyOncologyCancer GeneticsMolecular OncologyNeoplasiaApoptosis In CancerCancer Molecular PathologyDna Damage-induced ApoptosisMalignant NeoplasmsMolecular Classification Of TumorsTumor MarkersP53 AbnormalityP53 MutationTp53 MutationsTumor Suppressor P53
Accumulation of the p53 protein was analysed in 212 human malignant lesions. Immunohistochemical staining with new polyclonal (CM-1) and monoclonal antibodies (BP 53-12 and BP53-24) to p53 on methacarn-fixed paraffin sections showed positive staining in 161 (76%). The positive tumours were found across a wide range of human malignancies including breast, colon, stomach, bladder and testis carcinomas, soft-tissue sarcomas and melanomas. The staining was always confined to the malignant lesion. Immunoprecipitation and quantitative ELISA assays established that the positive staining was associated with accumulation of the protein and that the protein was frequently in a mutant conformation. Accumulation of mutant p53 protein is therefore a common feature of human malignant disease.